Fungal Frontlines: Novel Antifungals vs. Invasive Infections

December 12, 2024

Target Audience

All pharmacists

Learning Objectives

At the completion of this activity, the participant will be able to:


State the epidemiology, etiology, and risk factors associated with invasive fungal infections
State current guideline recommendations and treatment modalities for invasive fungal infections
Define the differences of novel antifungals based on mechanism of action and spectrum of activity
Describe the evidence supporting the use of these newer antifungal medications

Course summary
Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
12/03/2024
Course expires: 
04/09/2026
Event starts: 
12/12/2024 - 7:00pm EST
Event ends: 
12/12/2024 - 8:00pm EST
Cost:
$10.00
Add to calendar: 
Rating: 
0
ZOOM
United States

Christopher Donaldson is a PGY2 pharmacy resident in Infectious Diseases at The Brooklyn Hospital Center. Dr. Donaldson completed his PGY1 pharmacy residency at the Brooklyn Hospital Center. Upon completion of his PGY2, Dr. Donaldson hopes to pursue a fellowship in Infectious Diseases, with a focus on therapeutic drug monitoring in gram-positive infections.

 

 

 

 

ACPE UAN 0042-0000-24-075-L01-P

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$10.00
Please login or register to take this course.

Required Hardware/software

You will need a device that allows you to hear and see the presentation. Some phones may have limited functionality.